|
1
|
Gurney JG and Kadan-Lottick N: Brain and
other central nervous system tumors: Rates, trends, and
epidemiology. Curr Opin Oncol. 13:160–166. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Henriksson R, Asklund T and Poulsen HS:
Impact of therapy on quality of life, neurocognitive function and
their correlates in glioblastoma multiforme: A review. J
Neurooncol. 104:639–646. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Van Meir EG, Hadjipanayis CG, Norden AD,
Shu HK, Wen PY and Olson JJ: Exciting new advances in
neuro-oncology: The avenue to a cure for malignant glioma. CA
Cancer J Clin. 60:166–193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stupp R, Hegi ME, Gilbert MR and
Chakravarti A: Chemoradiotherapy in malignant glioma: Standard of
care and future directions. J Clin Oncol. 25:4127–4136. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu L, Nam YJ, Kung G, Crow MT and Kitsis
RN: Induction of the apoptosis inhibitor ARC by Ras in human
cancers. J Biol Chem. 285:19235–19245. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Y, Chen D, Qian H, Tsai YS, Shao S,
Liu Q, Dominguez D and Wang Z: The splicing factor RBM4 controls
apoptosis, proliferation, and migration to suppress tumor
progression. Cancer Cell. 26:374–389. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Y and Sun Y: Insulin-like growth
factor receptor-1 as an anti-cancer target: Blocking transformation
and inducing apoptosis. Curr Cancer Drug Targets. 2:191–207. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Resnicoff M, Abraham D, Yutanawiboonchai
W, Rotman HL, Kajstura J, Rubin R, Zoltick P and Baserga R: The
insulin-like growth factor I receptor protects tumor cells from
apoptosis in vivo. Cancer Res. 55:2463–2469. 1995.PubMed/NCBI
|
|
10
|
Dupont J and LeRoith D: Insulin and
insulin-like growth factor I receptors: Similarities and
differences in signal transduction. Horm Res. 55 Suppl 2:S22–S26.
2001.
|
|
11
|
Remacle-Bonnet MM, Garrouste FL, Heller S,
André F, Marvaldi JL and Pommier GJ: Insulin-like growth factor-I
protects colon cancer cells from death factor-induced apoptosis by
potentiating tumor necrosis factor alpha-induced mitogen-activated
protein kinase and nuclear factor kappaB signaling pathways. Cancer
Res. 60:2007–2017. 2000.PubMed/NCBI
|
|
12
|
Peruzzi F, Prisco M, Dews M, Salomoni P,
Grassilli E, Romano G, Calabretta B and Baserga R: Multiple
signaling pathways of the insulin-like growth factor 1 receptor in
protection from apoptosis. Mol Cell Biol. 19:7203–7215. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Entingh-Pearsall A and Kahn CR:
Differential roles of the insulin and insulin-like growth factor-I
(IGF-I) receptors in response to insulin and IGF-I. J Biol Chem.
279:38016–38024. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yasuda Y, Saito M, Yamamura T, Yaguchi T
and Nishizaki T: Extracellular adenosine induces apoptosis in
Caco-2 human colonic cancer cells by activating caspase-9/-3 via
A(2a) adenosine receptors. J Gastroenterol. 44:56–65. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma J, Liang S, Wang Z, Zhang L, Jiang J,
Zheng J, Yu L, Zheng X, Wang R and Zhu D: ROCK pathway participates
in the processes that 15-hydroxyeicosatetraenoic acid (15-HETE)
mediated the pulmonary vascular remodeling induced by hypoxia in
rat. J Cell Physiol. 222:82–94. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gopinath S, Alapati K, Malla RR, Gondi CS,
Mohanam S, Dinh DH and Rao JS: Mechanism of p27 upregulation
induced by downregulation of cathepsin B and uPAR in glioma. Mol
Oncol. 5:426–437. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gomez GG, Volinia S, Croce CM, Zanca C, Li
M, Emnett R, Gutmann DH, Brennan CW, Furnari FB and Cavenee WK:
Suppression of microRNA-9 by mutant EGFR signaling upregulates
FOXP1 to enhance glioblastoma tumorigenicity. Cancer Res.
74:1429–1439. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sawa H, Murakami H, Kumagai M, Nakasato M,
Yamauchi S, Matsuyama N, Tamura Y, Satone A, Ide W, Hashimoto I and
Kamada H: Histone deacetylase inhibitor, FK228, induces apoptosis
and suppresses cell proliferation of human glioblastoma cells in
vitro and in vivo. Acta Neuropathol. 107:523–531. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ziegler DS, Wright RD, Kesari S, Lemieux
ME, Tran MA, Jain M, Zawel L and Kung AL: Resistance of human
glioblastoma multiforme cells to growth factor inhibitors is
overcome by blockade of inhibitor of apoptosis proteins. J Clin
Invest. 118:3109–3122. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
DeAngelis T, Ferber A and Baserga R:
Insulin-like growth factor I receptor is required for the mitogenic
and transforming activities of the platelet-derived growth factor
receptor. J Cell Physiol. 164:214–221. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Coppola D, Ferber A, Miura M, Sell C,
D'Ambrosio C, Rubin R and Baserga R: A functional insulin-like
growth factor I receptor is required for the mitogenic and
transforming activities of the epidermal growth factor receptor.
Mol Cell Biol. 14:4588–4595. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pollak M: Insulin and insulin-like growth
factor signalling in neoplasia. Nat Rev Cancer. 8:915–928. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sell C, Dumenil G, Deveaud C, Miura M,
Coppola D, DeAngelis T, Rubin R, Efstratiadis A and Baserga R:
Effect of a null mutation of the insulin-like growth factor I
receptor gene on growth and transformation of mouse embryo
fibroblasts. Mol Cell Biol. 14:3604–3612. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zeigler ME, Krause S, Karmiol S and Varani
J: Growth factor-induced epidermal invasion of the dermis in human
skin organ culture: Dermal invasion correlated with epithelial cell
motility. Invasion Metastasis. 16:3–10. 1996.PubMed/NCBI
|
|
25
|
Long L, Rubin R, Baserga R and Brodt P:
Loss of the metastatic phenotype in murine carcinoma cells
expressing an antisense RNA to the insulin-like growth factor
receptor. Cancer Res. 55:1006–1009. 1995.PubMed/NCBI
|
|
26
|
Arcaro A: Targeting the insulin-like
growth factor-1 receptor in human cancer. Front Pharmacol.
4:302013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang L, Zhou F and ten Dijke P: Signaling
interplay between transforming growth factor-β receptor and
PI3K/AKT pathways in cancer. Trends Biochem Sci. 38:612–620. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Edwards LA, Thiessen B, Dragowska WH,
Daynard T, Bally MB and Dedhar S: Inhibition of ILK in PTEN-mutant
human glioblastomas inhibits PKB/Akt activation, induces apoptosis,
and delays tumor growth. Oncogene. 24:3596–3605. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shingu T, Yamada K, Hara N, Moritake K,
Osago H, Terashima M, Uemura T, Yamasaki T and Tsuchiya M:
Synergistic augmentation of antimicrotubule agent-induced
cytotoxicity by a phosphoinositide 3-kinase inhibitor in human
malignant glioma cells. Cancer Res. 63:4044–4047. 2003.PubMed/NCBI
|
